Abstract
This controlled clinical study investigated the clinical and radiographic outcome of wide intrabony periodontal defects treated by enamel matrix derivatives alone or in combination with a bioactive glass over a period of 8 months. Twenty-three chronic periodontitis patients, who received initial therapy and had radiographical interproximal defects with an associated probing depth of 6 mm or more and an intrabony component of at least 4 mm, were included. Each of the patients, contributing at least one intrabony defect, was treated with either enamel matrix derivative alone (group 1, n=10) or the combination (group 2, n=13). In both groups, all clinical and radiographical parameters were improved. Groups 1 and 2 presented a mean pocket reduction of 5.03±0.89 and 5.73±0.80 mm, recession of 0.97±0.24 and 0.56±0.18 mm, relative attachment gain of 4.06±1.06 and 5.17±0.85 mm, and radiographic bone gain of 2.15±0.42 and 2.76±0.69 mm, respectively. An intergroup comparison revealed significant differences for all of the parameters, yielding a more favorable outcome towards the combined approach. Within the limits of the study, both treatments resulted in marked clinical and radiographical improvements, but combined treatment seemed to enhance the results in the treatment of wide intrabony defects.
Similar content being viewed by others
References
Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Kenney EB, Madzarevic M (2001) The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans. J Clin Periodontol 28:1016–1022
Cattaneo V, Rota C, Silvestri M, Piacentini C, Forlino A, Gallanti A, Rasperini G, Cetta G (2003) Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study. J Periodontal Res 38:568–574
Christgau M, Schmalz G, Reich E, Wenzel A (1995) Clinical and radiographical split-mouth-study on resorbable versus non-resorbable GTR-membranes. J Clin Periodontol 22:306–315
Cochran DL, Jones A, Heijl L, Mellonig JT, Schoolfield J, King GN (2003) Periodontal regeneration with a combination of enamel matrix proteins and autogenous bone grafting. J Clin Periodontol 74:1269–1281
Cochran DL, King GN, Schoolfield J, Velasquez-Plata D, Mellonig JT, Jones A (2003) The effect of enamel matrix proteins on periodontal regeneration as determined by histological analyses. J Clin Periodontol 74:1043–1055
Donos N, Sculean A, Glavind L, Reich E, Karring T (2003) Wound healing of degree III furcation involvements following guided tissue regeneration and/or Emdogain. A histologic study. J Clin Periodontol 30:1061–1068
Fetner A, Hartigan M, Low S (1994) Periodontal repair using Perioglass in non-human primates: clinical and histological observations. Compendium (Newt. Pa.) 7:932–938
Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry. J Clin Periodontol 72:25–34
Garrett S (1996) Periodontal regeneration around natural teeth. In: Newman MG (ed) Annals of periodontology. The American Academy of Periodontology, Chicago, pp 621–666
Gunsolley J, Elswick RK, Davenport JM (1998) Equivalence and superiority testing in regeneration clinical trials. J Clin Periodontol 69:521–527
Haase H, Bartold PM (2001) Enamel matrix derivative induces matrix synthesis by cultured human periodontal fibroblast cells. J Clin Periodontol 72:341–348
Hammarstrom L (1997) Enamel matrix, cementum development and regeneration. J Clin Periodontol 24:658–668
Heden G (2000) A case report study of 72 consecutive Emdogain-treated intrabony defects: clinical and radiographic findings after 1 year. Int J Periodontics Restor Dent 20:127–139
Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693–696
Heijl L, Heden G, Svardström G, Östgren A (1997) Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705–714
Karatzas S, Zavras A, Greenspan D, Amar S (1999) Histologic observations of periodontal wound healing after treatment with PerioGlas in nonhuman primates. Int J Periodontics Restor Dent 19:489–499
Kılıç AR, Efeoğlu E, Yılmaz S (1997) Guided tissue regeneration in conjunction with hydroxyapatite-collagen grafts for intrabony defects. A clinical and radiological evaluation. J Clin Periodontol 24:372–383
Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Clin Periodontol 71:1110–1116
Lindhe J, Westfelt E, Nyman S, Socransky SS, Heijl L, Bratthall G (1982) Healing following surgical/non-surgical treatment of periodontal disease. A clinical study. J Clin Periodontol 9:115–128
Mellonig JT (1999) Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologic case report. Int J Periodontics Restor Dent 19:9–19
Mühlemann HR, Son S (1971) Gingival sulcus bleeding: a leading symptom in initial gingivitis. Helv Odontol Acta 15:107–112
Nevins ML, Camelo M, Nevins M, King CJ, Oringer RJ, Schenk RK, Fiorellini JP (2000) Human histologic evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontics Restor Dent 20:458–467
Pietruska MD (2001) A comparative study on the use of Bio-Oss and enamel matrix derivative (Emdogain) in the treatment of periodontal bone defects. Eur J Oral Sci 109:178–181
Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840
Quintero G, Mellonig JT, Gambill VM, Pelleu GB Jr (1982) A six-month clinical evaluation of decalcified freeze-dried bone allografts in periodontal osseous defects. J Clin Periodontol 53:726–730
Rosen P, Reynolds MA (2002) A retrospective case series comparing the use of demineralized freeze-dried bone allograft and freeze-dried bone allograft combined with enamel matrix derivative for the treatment of advanced osseous lesions. J Clin Periodontol 73:942–949
Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mellonig JT (2002) A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects. J Clin Periodontol 73:423–432
Sculean A, Donos N, Blaes A, Lauermann M, Reich E, Brecx M (1999) Comparison of enamel matrix proteins an bioabsorbable membranes in the treatment of intrabony defects. A split-mouth study. J Clin Periodontol 70:255–262
Sculean A, Donos N, Windisch P, Gera I, Brecx M, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310–322
Sculean A, Reich E, Chiantella CG, Brecx M (1999) Treatment of intrabony periodontal defects with an enamel matrix protein derivative (Emdogain): a report of 32 cases. Int J Periodontics Restor Dent 19:157–163
Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain). Int J Periodontics Restor Dent 20:375–381
Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 27:466–472
Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397–403
Sculean A, Barbe G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M (2002) Clinical evaluation of an enamel matrix derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Clin Periodontol 73:401–408
Sculean A, Windisch P, Keglevich T, Fabi B, Lundgren E, Lyngstadaas PS (2002) Presence of an enamel matrix protein derivative on human teeth following periodontal surgery. Clin Oral Investig 6:183–187
Sculean A, Windisch P, Keglevich T, Chiantella CG, Gera I, Donos N (2003) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine derived xenograft. Int J Periodontics Restor Dent 23:47–55
Sculean A, Pietruska M, Schwartz F, Willershausen B, Arweiler NB, Auschill TM (2005) Healing of human intrabony defects following regenerative periodontal therapy with an enemal matrix protein derivative alone and combinated with a bioactive glass. J Clin Periodontol 32:111–117
Sculean A, Windisch P, Keglevich Gera I (2005) Clinical and histologic evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. Int J Periodontics Restor Dent 25:139–147
Silness J, Löe H (1964) Periodontal disease in pregnancy (II). Correlation between oral hygiene and periodontal conditioning. Acta Odontol Scand 22:121–135
Silverstein LH (2005) Suture selection for optimal flap closure and tissue healing. Perio-implant showcase. Pract Periodontics Aesthet Dent 16:2–3
Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V (2000) Comparison of treatments of intrabony defects with enamel matrix derivative, guided tissue regeneration with a nonresorbable membrane and Widman modified flap. A pilot study. J Clin Periodontol 27:603–610
Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adrian P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedman C, Topoll H, Vangsted T, Walkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 9:317–325
Velasquez-Plata D, Scheyer TE, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Clin Periodontol 73:433–440
Wikesjö UME, Selvig KA (1999) Periodontal wound healing and regeneration. Periodontol 2000 19:21–39
Wilson J, Low (1992) Bioactive ceramics for periodontal treatment: comparative study in the patus monkey. J Appl Biomater 3:123–129
Wilson J, Clark AE, Hall M, Hench LL (1993) Tissue response to Bioglass endosseous ridge maintenance implants. J Oral Implantol 19:295–302
Yılmaz S, Kuru B, Altuna-Kırac E (2003) Enamel matrix proteins in the treatment of periodontal sites with horizontal type of bone loss. J Clin Periodontol 30:197–206
Yukna RA, Mellonig J (2000) Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 71:752–759
Zetterström O, Andersson C, Eriksson C (1997) Clinical safety of enamel matrix derivative (EMDOGAIN) in the treatment of periodontal defects. J Clin Periodontol 24:697–704
Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:1725–1735
Acknowledgement
The authors would like to thank Asst. Prof. Cem S. Sütcü for his statistical support in analyzing the data.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuru, B., Yılmaz, S., Argın, K. et al. Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects. Clin Oral Invest 10, 227–234 (2006). https://doi.org/10.1007/s00784-006-0052-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-006-0052-5